<?xml version="1.0" encoding="UTF-8"?>
<document id="DDI-DrugBank.d272">
    <sentence id="DDI-DrugBank.d272.s0" text="The risk of using bromocriptine mesylate in combination with other drugs has not been systematically evaluated, but alcohol may potentiate the side effects of bromocriptine mesylate.">
        <entity id="DDI-DrugBank.d272.s0.e0" charOffset="18-39"
            type="drug" text="bromocriptine mesylate"/>
        <entity id="DDI-DrugBank.d272.s0.e1" charOffset="116-122"
            type="drug" text="alcohol"/>
        <entity id="DDI-DrugBank.d272.s0.e2" charOffset="159-180"
            type="drug" text="bromocriptine mesylate"/>
        <ddi id="DDI-DrugBank.d272.s0.d0" e1="DDI-DrugBank.d272.s0.e1"
            e2="DDI-DrugBank.d272.s0.e2" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d272.s1" text="Bromocriptine mesylate may interact with dopamine antagonists, butyrophenones, and certain other agents.">
        <entity id="DDI-DrugBank.d272.s1.e0" charOffset="0-21"
            type="drug" text="Bromocriptine mesylate"/>
        <entity id="DDI-DrugBank.d272.s1.e1" charOffset="41-60"
            type="group" text="dopamine antagonists"/>
        <entity id="DDI-DrugBank.d272.s1.e2" charOffset="63-76"
            type="group" text="butyrophenones"/>
        <ddi id="DDI-DrugBank.d272.s1.d0" e1="DDI-DrugBank.d272.s1.e0"
            e2="DDI-DrugBank.d272.s1.e1" type="int"/>
        <ddi id="DDI-DrugBank.d272.s1.d1" e1="DDI-DrugBank.d272.s1.e0"
            e2="DDI-DrugBank.d272.s1.e2" type="int"/>
    </sentence>
    <sentence id="DDI-DrugBank.d272.s2" text="Compounds in these categories result in a decreased efficacy of bromocriptine mesylate: phenothiazines, haloperidol, metoclopramide, pimozide.">
        <entity id="DDI-DrugBank.d272.s2.e0" charOffset="64-85"
            type="drug" text="bromocriptine mesylate"/>
        <entity id="DDI-DrugBank.d272.s2.e1" charOffset="88-101"
            type="group" text="phenothiazines"/>
        <entity id="DDI-DrugBank.d272.s2.e2" charOffset="104-114"
            type="drug" text="haloperidol"/>
        <entity id="DDI-DrugBank.d272.s2.e3" charOffset="117-130"
            type="drug" text="metoclopramide"/>
        <entity id="DDI-DrugBank.d272.s2.e4" charOffset="133-140"
            type="drug" text="pimozide"/>
        <ddi id="DDI-DrugBank.d272.s2.d0" e1="DDI-DrugBank.d272.s2.e0"
            e2="DDI-DrugBank.d272.s2.e1" type="effect"/>
        <ddi id="DDI-DrugBank.d272.s2.d1" e1="DDI-DrugBank.d272.s2.e0"
            e2="DDI-DrugBank.d272.s2.e2" type="effect"/>
        <ddi id="DDI-DrugBank.d272.s2.d2" e1="DDI-DrugBank.d272.s2.e0"
            e2="DDI-DrugBank.d272.s2.e3" type="effect"/>
        <ddi id="DDI-DrugBank.d272.s2.d3" e1="DDI-DrugBank.d272.s2.e0"
            e2="DDI-DrugBank.d272.s2.e4" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d272.s3" text="Concomitant use of bromocriptine mesylate with other ergot alkaloids is not recommended.">
        <entity id="DDI-DrugBank.d272.s3.e0" charOffset="19-40"
            type="drug" text="bromocriptine mesylate"/>
        <entity id="DDI-DrugBank.d272.s3.e1" charOffset="53-67"
            type="group" text="ergot alkaloids"/>
        <ddi id="DDI-DrugBank.d272.s3.d0" e1="DDI-DrugBank.d272.s3.e0"
            e2="DDI-DrugBank.d272.s3.e1" type="advise"/>
    </sentence>
</document>
